These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16990718)

  • 1. Variants of human papillomavirus types 16 and 18: histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear.
    Rabelo-Santos SH; Villa LL; Derchain SF; Ferreira S; Sarian LO; Angelo-Andrade LA; do Amaral Westin MC; Zeferino LC
    Int J Gynecol Pathol; 2006 Oct; 25(4):393-7. PubMed ID: 16990718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ.
    Rabelo-Santos SH; Derchain SF; Villa LL; Costa MC; Sarian LO; do Amaral Westin MC; Kornegay J; Zeferino LC
    Int J Gynecol Pathol; 2009 May; 28(3):272-8. PubMed ID: 19620946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
    Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
    Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2.
    Zhao Y; Cao X; Zheng Y; Tang J; Cai W; Wang H; Gao Y; Wang Y
    J Med Virol; 2012 Dec; 84(12):1920-7. PubMed ID: 23080497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Derchain SF; Rabelo-Santos SH; Sarian LO; Zeferino LC; de Oliveira Zambeli ER; do Amaral Westin MC; de Angelo Andrade LA; Syrjänen KJ
    Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Komatsu H; Oishi T; Osaku D; Sawada M; Kudoh A; Nonaka M; Chikumi J; Sato S; Harada T
    Acta Cytol; 2018; 62(5-6):405-410. PubMed ID: 29990964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocervical glandular cell abnormalities in conventional cervical smears: evaluation of the performance of cytomorphological criteria and HPV testing in predicting neoplasia.
    Rabelo-Santos SH; Derchain SF; do Amaral Westin MC; Angelo-Andrade LA; Sarian LO; Oliveira ER; Morais SS; Zeferino LC
    Cytopathology; 2008 Feb; 19(1):34-43. PubMed ID: 18205627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
    Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
    Harbhajanka A; Dahoud W; Michael CW
    Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities.
    de Oliveira ER; Derchain SF; Sarian LO; Rabelo-Santos SH; Gontijo RC; Yoshida A; Andrade LA; Zeferino LC
    Int J Gynecol Cancer; 2006; 16(3):1055-62. PubMed ID: 16803485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
    Chang YJ; Chen HC; Lee BH; You SL; Lin CY; Pan MH; Chou YC; Hsieh CY; Chen YM; Cheng YJ; Chen CJ;
    Int J Cancer; 2011 Aug; 129(4):965-73. PubMed ID: 20949622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L; Baker P; Gup C; Shroyer KR
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
    Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
    Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
    Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
    J Korean Med Sci; 2021 Jun; 36(24):e164. PubMed ID: 34155836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
    Quint KD; de Koning MN; Geraets DT; Quint WG; Pirog EC
    Gynecol Oncol; 2009 Sep; 114(3):390-4. PubMed ID: 19500822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.
    Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT;
    J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.